Q2 2017 Holdings
Filed 2018-03-02 | 60 holdings | $33.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $16.6M | 61,108 | 49.8% |
| Biomarin Pharmaceuticals Inc(BMRN) | COM | 09061G101 | $10.7M | 118,166 | 32.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.8M | 137,773 | 11.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.9M | 37,000 | 5.7% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $23.6K | 48,130 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $23.1K | 177,522 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $17.5K | 135,522 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $11.8K | 96,641 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $9.8K | 77,475 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $8.6K | 50,104 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $8.6K | 121,784 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $5.7K | 341,468 | 0.0% |
| Mylan NV | SHS EURO | N59465109 | $5.4K | 140,000 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $5.4K | 32,700 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $5.4K | 177,643 | 0.0% |
| Radius Health Inc | COM | 750469207 | $5.2K | 114,799 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $5.1K | 207,000 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $5.0K | 168,025 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.9K | 93,822 | 0.0% |
| Tesaro Inc | COM | 881569107 | $4.7K | 33,500 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $4.3K | 76,000 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $4.2K | 27,000 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $4.2K | 453,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $3.8K | 129,000 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $3.6K | 244,000 | 0.0% |
| Synergy Pharmaceuticals del | COM | 871639308 | $3.4K | 772,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $3.4K | 65,000 | 0.0% |
| Achaogen Inc | COM | 004449104 | $3.4K | 154,538 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $3.3K | 35,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $3.2K | 185,234 | 0.0% |
| United Therapeutics Corp del | COM | 91307C109 | $2.8K | 21,700 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $2.7K | 320,744 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $2.6K | 204,633 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.6K | 51,500 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $2.4K | 13,641 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $2.3K | 22,100 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.3K | 322,436 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $2.3K | 42,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.1K | 61,000 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $2.0K | 169,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.7K | 358,975 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $1.4K | 170,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.4K | 58,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.4K | 16,996 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $1.4K | 11,155 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $1.2K | 41,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $1.1K | 59,000 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM | 53220K504 | $1.1K | 9,000 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $1.0K | 62,905 | 0.0% |
| Merus NV | COM | N5749R100 | $966 | 60,946 | 0.0% |